Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions
NCT01074450
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Pramipexole Dihydrochloride
DRUG:
Pramipexole Dihydrochloride
Sponsor
Teva Pharmaceuticals USA